GILD

Gilead Sciences
D

GILD

Arincen87/100B
166.870
USD
-0.73
(-0.44%)
Pre Open·168.040USD+1.170(+0.70%)
Last updated: · Delayed 15 min

Gilead Sciences current ratio

Gilead Sciences's current ratio is 1.38: current assets of 16.55B USD against current liabilities of 12.00B USD due within a year.

Today
1.38
Average, 5 years
1.36
Low, 5 years
1.02
High, 5 years
1.97

Current ratio = current assets ÷ current liabilities = 16.55B ÷ 12.00B = 1.38

Current ratio
Total current assets
Total current liabilities

Current assets over current liabilities at each quarter end: above 1, what falls due within a year is covered by what turns into cash within a year.

Current ratio by year and by quarter

Fiscal yearPeriod endingCurrent ratioTotal current assetsTotal current liabilities
Today1.3816.55B12.00B
FY202531 Dec 20251.5518.34B11.81B
FY202431 Dec 20241.6019.17B12.00B
FY202331 Dec 20231.4316.09B11.28B
FY202231 Dec 20221.2914.44B11.24B
FY202131 Dec 20211.2714.77B11.61B
FY202031 Dec 20201.4016.00B11.40B
FY201931 Dec 20193.1030.30B9.76B
FY201831 Dec 20183.3835.84B10.61B
FY201731 Dec 20172.7431.82B11.64B
FY201631 Dec 20162.1219.59B9.22B
FY201531 Dec 20152.5024.76B9.89B
FY201431 Dec 20143.0717.71B5.76B
FY201331 Dec 20131.097.00B6.41B
FY201231 Dec 20121.456.16B4.24B
FY201131 Dec 20115.5313.92B2.51B
FY201031 Dec 20102.325.71B2.46B
FY200931 Dec 20092.574.81B1.87B
FY200831 Dec 20083.504.28B1.22B
FY200731 Dec 20074.113.03B736.28M
FY200631 Dec 20063.182.43B764.28M
FY200531 Dec 20056.653.09B465.16M
FY200431 Dec 20047.301.85B253.45M
FY200331 Dec 20036.811.27B185.90M
FY200231 Dec 200211.291.18B104.89M
FY200131 Dec 20018.83707.76M80.12M
FY200031 Dec 200010.20593.80M58.24M
FY199931 Dec 19997.77371.98M47.88M
FY199831 Dec 19987.28416.90M57.30M
FY199731 Dec 199710.19340.30M33.40M
FY199631 Dec 199618.65300.30M16.10M
FY199531 Dec 199513.44157.20M11.70M
FY199431 Dec 19948.3691.10M10.90M
FY199231 Dec 199222.25140.20M6.30M
FY199131 Dec 199144.25106.20M2.40M
FY199031 Dec 19905.7810.40M1.80M

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.

See also:P/E ratio,Market cap,P/S ratio,Dividend yield,ROE (return on equity),Debt to equity,All ratios

Common questions about Gilead Sciences's current ratio

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.